documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
82 rows where agency_id = "DEA" and posted_year = 2020 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, comment_end_date, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Rule 32
- Supporting & Related Material 25
- Proposed Rule 18
- Notice 5
- Other 2
posted_year 1
- 2020 · 82 ✖
agency_id 1
- DEA · 82 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEA-2020-0038-0003 | DEA | Schedules of Controlled Substances: Placement of Brorphine in Schedule I DEA-2020-0038 | Three Factor Analysis for Temporary Control of Brorphine 11022020 clean_DOE-20-464 | Other | 2020-12-23T05:00:00Z | 2020 | 12 | 2020-12-23T05:00:00Z | 2020-12-23T19:27:46Z | 0 | 0 | 09000064849c3ac5 | |||
| DEA-2020-0038-0002 | DEA | Schedules of Controlled Substances: Placement of Brorphine in Schedule I DEA-2020-0038 | Three Factor Analysis for Temporary Control of Brorphine | Other | 2020-12-23T00:00:00Z | 2020 | 12 | 2020-12-23T19:21:40Z | 0 | 1 | 09000064849c266d | ||||
| DEA-2021-0001-0001 | DEA | Designation of APAA, PMK glycidate and PMK glycidic acid as List I chemicals DEA-2021-0001 | Designation of 3,4-MDP-2-P methyl glycidate (PMK glycidate), 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid), and alpha-phenylacetoacetamide (APAA) as List I Chemicals | Proposed Rule | 2020-12-21T05:00:00Z | 2020 | 12 | 2020-12-21T05:00:00Z | 2021-02-20T04:59:59Z | 2021-02-25T13:50:56Z | 2020-26813 | 0 | 0 | 09000064849aefe0 | |
| DEA-2020-0008-0255 | DEA | Controls To Enhance the Cultivation of Marihuana for Research in the United States DEA-2020-0008 | Controls to Enhance the Cultivation of Marihuana for Research in the United States | Rule | 2020-12-18T05:00:00Z | 2020 | 12 | 2020-12-18T05:00:00Z | 2021-01-04T15:14:48Z | 2020-27999 | 0 | 0 | 09000064849a768d | ||
| DEA-2021-0002-0001 | DEA | Schedules of Controlled Substances: Exempt Anabolic Steroid Products DEA-2021-0002 | Schedules of Controlled Substances: Exempt Anabolic Steroid Products | Rule | 2020-12-16T05:00:00Z | 2020 | 12 | 2020-12-16T05:00:00Z | 2021-02-17T04:59:59Z | 2021-01-06T18:55:28Z | 2020-25288 | 0 | 0 | 09000064849a1ba4 | |
| DEA-2021-0004-0001 | DEA | Schedules of Controlled Substances: Removal of Samidorphan from Control DEA-2021-0004 | Schedules of Controlled Substances: Removal of Samidorphan From Control | Proposed Rule | 2020-12-10T05:00:00Z | 2020 | 12 | 2020-12-10T05:00:00Z | 2021-01-12T04:59:59Z | 2021-01-12T02:00:35Z | 2020-26812 | 0 | 0 | 090000648499556e | |
| DEA_FRDOC_0001-0330 | DEA | Recently Posted DEA Rules and Notices DEA_FRDOC_0001 | Samidorphan_DEA_8F analysis_10-15-2020 | Supporting & Related Material | 2020-12-10T00:00:00Z | 2020 | 12 | 2022-07-19T12:59:45Z | 0 | 1 | 0900006484995f8f | ||||
| DEA_FRDOC_0001-0329 | DEA | Recently Posted DEA Rules and Notices DEA_FRDOC_0001 | HHS Samidorphan 2020 01-09 | Supporting & Related Material | 2020-12-10T00:00:00Z | 2020 | 12 | 2022-07-19T13:00:03Z | 0 | 1 | 0900006484995f8b | ||||
| DEA-2020-0035-0001 | DEA | Partial Filling of Prescriptions for Schedule II Controlled Substances DEA-2020-0035 | Partial Filling of Prescriptions for Schedule II Controlled Substances | Proposed Rule | 2020-12-04T05:00:00Z | 2020 | 12 | 2020-12-04T05:00:00Z | 2021-02-03T04:59:59Z | 2021-02-03T02:00:28Z | 2020-26291 | 0 | 0 | 0900006484985b6b | |
| DEA-2020-0038-0001 | DEA | Schedules of Controlled Substances: Placement of Brorphine in Schedule I DEA-2020-0038 | Schedules of Controlled Substances: Temporary Placement of Brorphine in Schedule I | Proposed Rule | 2020-12-03T05:00:00Z | 2020 | 12 | 2020-12-03T05:00:00Z | 2020-12-23T16:19:53Z | 2020-26301 | 0 | 0 | 090000648498412a | ||
| DEA-2019-0008-0748 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020 DEA-2019-0008 | 2020 Final APQ and AAN | Notice | 2020-12-01T05:00:00Z | 2020 | 12 | 2020-12-01T05:00:00Z | 2020-12-01T16:22:10Z | 0 | 0 | 090000648497fdcc | |||
| DEA-2020-0026-0297 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021 DEA-2020-0026 | 2021 APQ and AAN (Established) | Notice | 2020-12-01T05:00:00Z | 2020 | 12 | 2020-12-01T05:00:00Z | 2020-12-01T16:38:41Z | 0 | 0 | 090000648497fc36 | |||
| DEA-2020-0002-0012 | DEA | Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 | Schedules of Controlled Substances: Placement of Cyclopentyl Fentanyl, Isobutyryl Fentanyl, Para-chloroisobutyryl Fentanyl, Para-methoxybutyryl Fentanyl, and Valeryl Fentanyl in Schedule I | Rule | 2020-11-25T05:00:00Z | 2020 | 11 | 2020-11-25T05:00:00Z | 2020-12-03T14:36:18Z | 2020-22757 | 0 | 0 | 09000064849757f9 | ||
| DEA-2020-0031-0001 | DEA | Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment DEA-2020-0031 | Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment | Rule | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T05:00:00Z | 2021-01-05T04:59:59Z | 2021-01-06T02:01:18Z | 2020-23813 | 0 | 0 | 0900006484945a60 | |
| DEA-2021-0003-0001 | DEA | Suspicious Orders of Controlled Substances DEA-2021-0003 | Suspicious Orders of Controlled Substances | Proposed Rule | 2020-11-02T05:00:00Z | 2020 | 11 | 2020-11-02T05:00:00Z | 2021-01-05T04:59:59Z | 2021-02-25T16:35:27Z | 2020-21302 | 0 | 0 | 0900006484945a99 | |
| DEA-2020-0032-0001 | DEA | Schedules of Controlled Substances: Placement of Oliceridine in Schedule II DEA-2020-0032 | Schedules of Controlled Substances: Placement of Oliceridine in Schedule II | Rule | 2020-10-30T04:00:00Z | 2020 | 10 | 2020-10-30T04:00:00Z | 2020-12-01T04:59:59Z | 2020-11-23T02:01:02Z | 2020-22762 | 0 | 0 | 0900006484941681 | |
| DEA-2020-0033-0001 | DEA | Implementation of the Combat Methamphetamine Epidemic Act: Retail Sales; Transfers Following Importation or Exportation DEA-2020-0033 | Implementation of the Combat Methamphetamine Epidemic Act: Retail Sales; Transfers Following Importation or Exportation | Rule | 2020-10-29T04:00:00Z | 2020 | 10 | 2020-10-29T04:00:00Z | 2020-11-13T20:35:20Z | 2020-19311 | 0 | 0 | 090000648493e2ba | ||
| DEA-2020-0030-0002 | DEA | Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 DEA-2020-0030 | Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act; Correction | Rule | 2020-10-22T04:00:00Z | 2020 | 10 | 2020-10-22T04:00:00Z | 2020-11-13T14:26:56Z | 2020-22761 | 0 | 0 | 0900006484925d39 | ||
| DEA-2020-0009-0005 | DEA | Schedules of Controlled Substances: Placement of 4,4'-DMAR in Schedule I DEA-2020-0009 | 4, 4'-DMAR HHS ltr and 8 Factor Analysis -2018 (1) | Supporting & Related Material | 2020-10-20T04:00:00Z | 2020 | 10 | 2020-10-20T16:24:31Z | 0 | 0 | 090000648491b75c | ||||
| DEA-2020-0009-0004 | DEA | Schedules of Controlled Substances: Placement of 4,4'-DMAR in Schedule I DEA-2020-0009 | 4 4'-DMAR DEA 8 Factor Analysis 03-10-2020 | Supporting & Related Material | 2020-10-20T04:00:00Z | 2020 | 10 | 2020-10-20T10:57:55Z | 0 | 0 | 0900006484917a3d | ||||
| DEA-2020-0028-0002 | DEA | Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV DEA-2020-0028 | Remimazolam DEA 658 8-factor | Supporting & Related Material | 2020-10-08T04:00:00Z | 2020 | 10 | 2020-10-08T17:05:13Z | 0 | 0 | 09000064848ed460 | ||||
| DEA-2020-0028-0003 | DEA | Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV DEA-2020-0028 | FINAL SIGNED ASH Response to DEA Remimazolam_04162020 | Supporting & Related Material | 2020-10-08T04:00:00Z | 2020 | 10 | 2020-10-08T19:19:33Z | 0 | 0 | 09000064848edc25 | ||||
| DEA-2020-0028-0001 | DEA | Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV DEA-2020-0028 | Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV | Rule | 2020-10-06T04:00:00Z | 2020 | 10 | 2020-10-06T04:00:00Z | 2020-11-06T04:59:59Z | 2020-11-07T02:00:38Z | 2020-19313 | 0 | 0 | 09000064848dc25c | |
| DEA-2020-0029-0001 | DEA | Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017 DEA-2020-0029 | Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017 | Proposed Rule | 2020-10-05T04:00:00Z | 2020 | 10 | 2020-10-05T04:00:00Z | 2020-12-05T04:59:59Z | 2020-12-06T02:00:55Z | 2020-21675 | 0 | 0 | 09000064848ce421 | |
| DEA-2020-0034-0001 | DEA | Schedules of Controlled Substances: Placement of Crotonyl Fentanyl in Schedule I DEA-2020-0034 | Schedules of Controlled Substances: Placement of Crotonyl Fentanyl in Schedule I | Rule | 2020-10-02T04:00:00Z | 2020 | 10 | 2020-10-02T04:00:00Z | 2020-12-08T16:43:11Z | 2020-19305 | 0 | 0 | 09000064848b5019 | ||
| DEA-2020-0030-0001 | DEA | Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 DEA-2020-0030 | Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act | Rule | 2020-09-30T04:00:00Z | 2020 | 9 | 2020-10-07T14:52:01Z | 2020-21310 | 0 | 0 | 09000064848a25c4 | |||
| DEA-2020-0027-0001 | DEA | Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration DEA-2020-0027 | Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration | Proposed Rule | 2020-09-30T04:00:00Z | 2020 | 9 | 2020-09-30T04:00:00Z | 2020-12-01T04:59:59Z | 2020-12-01T02:02:00Z | 2020-19309 | 0 | 0 | 09000064848a25f0 | |
| DEA-2020-0026-0001 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021 DEA-2020-0026 | Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021 | Notice | 2020-09-01T04:00:00Z | 2020 | 9 | 2020-09-01T04:00:00Z | 2020-10-02T03:59:59Z | 2020-10-03T01:01:50Z | 0 | 0 | 09000064848340df | ||
| DEA-2019-0008-0738 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020 DEA-2019-0008 | Proposed Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020 | Notice | 2020-09-01T04:00:00Z | 2020 | 9 | 2020-09-01T04:00:00Z | 2020-10-02T03:59:59Z | 2020-10-03T01:03:58Z | 0 | 0 | 0900006484833ad7 | ||
| DEA-2020-0025-0002 | DEA | Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I DEA-2020-0025 | DEA 482 N-Ethylpentylone 8 Factor | Supporting & Related Material | 2020-08-28T04:00:00Z | 2020 | 8 | 2020-08-28T14:32:25Z | 0 | 0 | 0900006484824f5e | ||||
| DEA-2020-0025-0003 | DEA | Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I DEA-2020-0025 | FINAL SIGNED ASH Letter to DEA_8 Factor Analysis for N-ethylpentylone | Supporting & Related Material | 2020-08-28T04:00:00Z | 2020 | 8 | 2020-08-28T14:32:37Z | 0 | 0 | 0900006484824f5f | ||||
| DEA-2020-0025-0001 | DEA | Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I DEA-2020-0025 | Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I | Proposed Rule | 2020-08-27T04:00:00Z | 2020 | 8 | 2020-08-27T04:00:00Z | 2020-09-29T03:59:59Z | 2020-09-28T01:01:08Z | 2020-19007 | 0 | 0 | 0900006484823d52 | |
| DEA-2020-0024-0001 | DEA | Schedules of Controlled Substances: Extension of Temporary Placement of N-Ethylpentylone in Schedule I of the Controlled Substances Act DEA-2020-0024 | Schedules of Controlled Substances: Extension of Temporary Placement of N-Ethylpentylone in Schedule I of the Controlled Substances Act | Rule | 2020-08-27T04:00:00Z | 2020 | 8 | 2020-08-27T04:00:00Z | 2020-08-27T16:50:39Z | 2020-19011 | 0 | 0 | 0900006484823c45 | ||
| DEA-2020-0023-0001 | DEA | Implementation of the Agricultural Improvement Act DEA-2020-0023 | Implementation of the Agriculture Improvement Act of 2018 | Rule | 2020-08-21T04:00:00Z | 2020 | 8 | 2020-08-21T04:00:00Z | 2020-10-21T03:59:59Z | 2020-10-22T01:02:32Z | 2020-17356 | 0 | 0 | 09000064848168ac | |
| DEA-2020-0017-0004 | DEA | Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I DEA-2020-0017 | Three Factor Analysis for Temporary Control of Isotonitazene (DEA631) 07.21.20 | Supporting & Related Material | 2020-08-21T04:00:00Z | 2020 | 8 | 2020-08-21T07:35:45Z | 0 | 0 | 0900006484815d4e | ||||
| DEA-2020-0017-0003 | DEA | Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I DEA-2020-0017 | Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I | Rule | 2020-08-20T04:00:00Z | 2020 | 8 | 2020-08-20T04:00:00Z | 2020-08-20T20:50:10Z | 2020-17951 | 0 | 0 | 0900006484813e61 | ||
| DEA-2020-0006-0007 | DEA | Schedules of Controlled Substances: Placement of Cenobamate in Schedule V DEA-2020-0006 | Schedules of Controlled Substances: Placement of Cenobamate in Schedule V | Rule | 2020-08-20T04:00:00Z | 2020 | 8 | 2020-08-20T04:00:00Z | 2020-08-21T18:10:51Z | 2020-17357 | 0 | 0 | 0900006484813f86 | ||
| DEA-2020-0003-0007 | DEA | Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V DEA-2020-0003 | Lasmiditan HHS ltr and 8 Factor Analysis | Supporting & Related Material | 2020-08-17T04:00:00Z | 2020 | 8 | 2020-08-17T14:35:42Z | 0 | 0 | 0900006484807b97 | ||||
| DEA-2020-0003-0008 | DEA | Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V DEA-2020-0003 | 8F Lasmiditan 06102020 | Supporting & Related Material | 2020-08-17T00:00:00Z | 2020 | 8 | 2020-08-27T14:18:38Z | 0 | 1 | 0900006484807b98 | ||||
| DEA-2020-0022-0001 | DEA | Reporting of Theft or Significant Loss of Controlled Substances DEA-2020-0022 | Reporting of Theft or Significant Loss of Controlled Substances | Proposed Rule | 2020-07-29T04:00:00Z | 2020 | 7 | 2020-07-29T04:00:00Z | 2020-09-29T03:59:59Z | 2020-09-28T01:01:01Z | 2020-15635 | 0 | 0 | 09000064847b3625 | |
| DEA-2020-0007-0015 | DEA | Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants DEA-2020-0007 | Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants | Rule | 2020-07-24T04:00:00Z | 2020 | 7 | 2020-08-03T18:03:47Z | 2020-16169 | 0 | 0 | 09000064847a240b | |||
| DEA-2020-0020-0001 | DEA | Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I DEA-2020-0020 | Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I | Proposed Rule | 2020-07-13T04:00:00Z | 2020 | 7 | 2020-07-13T04:00:00Z | 2020-08-13T03:59:59Z | 2020-08-13T01:01:57Z | 2020-14901 | 0 | 0 | 0900006484745b40 | |
| DEA-2020-0021-0001 | DEA | Schedules of Controlled Substances: Extension of Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I of the Controlled Substances Act DEA-2020-0021 | Schedules of Controlled Substances: Extension of Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA in Schedule I of the Controlled Substances Act | Rule | 2020-07-13T04:00:00Z | 2020 | 7 | 2020-07-13T04:00:00Z | 2020-07-17T14:08:49Z | 2020-14902 | 0 | 0 | 0900006484745b77 | ||
| DEA-2020-0017-0002 | DEA | Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I DEA-2020-0017 | Three Factor Analysis for Temporary Control of Isotonitazene (DEA631) CLEAN 05052020 (1) | Supporting & Related Material | 2020-06-19T00:00:00Z | 2020 | 6 | 2020-08-21T07:31:31Z | 0 | 1 | 09000064846fae6c | ||||
| DEA-2020-0017-0001 | DEA | Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I DEA-2020-0017 | Schedules of Controlled Substances: Temporary Placement of Isotonitazene in Schedule I | Proposed Rule | 2020-06-18T04:00:00Z | 2020 | 6 | 2020-06-18T04:00:00Z | 2020-06-19T13:24:57Z | 2020-12304 | 0 | 0 | 09000064846f8a81 | ||
| DEA-2020-0018-0001 | DEA | Schedules of Controlled Substances: Exempt Anabolic Steroid Products DEA-2020-0018 | Schedules of Controlled Substances: Exempt Anabolic Steroid Products | Rule | 2020-06-15T04:00:00Z | 2020 | 6 | 2020-06-15T04:00:00Z | 2020-08-15T03:59:59Z | 2020-06-27T01:02:19Z | 2020-11318 | 0 | 0 | 09000064846eebee | |
| DEA-2020-0019-0001 | DEA | Listing of Ethylone in the Code of Federal Regulations and Assignment of an Administration Controlled Substances Code Number DEA-2020-0019 | Listing of Ethylone in the Code of Federal Regulations and Assignment of an Administration Controlled Substances Code Number | Rule | 2020-06-08T04:00:00Z | 2020 | 6 | 2020-06-08T04:00:00Z | 2020-07-17T14:04:09Z | 2020-10295 | 0 | 0 | 09000064846d38f0 | ||
| DEA-2020-0016-0003 | DEA | Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I DEA-2020-0016 | PMMA-HHS recommendation | Supporting & Related Material | 2020-05-26T04:00:00Z | 2020 | 5 | 2020-05-26T16:55:22Z | 0 | 0 | 09000064846ae01e | ||||
| DEA-2020-0015-0005 | DEA | Schedules of Controlled Substances: Placement of Zipeprol in Schedule I DEA-2020-0015 | Zipeprol 8 Factor HHS 05202013 | Supporting & Related Material | 2020-05-26T04:00:00Z | 2020 | 5 | 2020-05-26T15:18:48Z | 0 | 0 | 09000064846ad53d | ||||
| DEA-2020-0015-0004 | DEA | Schedules of Controlled Substances: Placement of Zipeprol in Schedule I DEA-2020-0015 | Zipeprol 8 Factor May 2020 | Supporting & Related Material | 2020-05-26T04:00:00Z | 2020 | 5 | 2020-05-26T15:18:40Z | 0 | 0 | 09000064846ad53b | ||||
| DEA-2020-0016-0002 | DEA | Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I DEA-2020-0016 | PMMA 8-factor review document | Supporting & Related Material | 2020-05-26T04:00:00Z | 2020 | 5 | 2020-05-26T16:55:10Z | 0 | 0 | 09000064846ae01d | ||||
| DEA-2020-0015-0003 | DEA | Schedules of Controlled Substances: Placement of Zipeprol in Schedule I DEA-2020-0015 | Zipeprol HHS Letter 05202013 | Supporting & Related Material | 2020-05-26T04:00:00Z | 2020 | 5 | 2020-05-26T15:18:29Z | 0 | 0 | 09000064846ad90a | ||||
| DEA-2020-0016-0001 | DEA | Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I DEA-2020-0016 | Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I | Proposed Rule | 2020-05-15T04:00:00Z | 2020 | 5 | 2020-05-15T04:00:00Z | 2020-06-16T03:59:59Z | 2020-05-26T16:52:37Z | 2020-09599 | 0 | 0 | 090000648460372c | |
| DEA-2020-0015-0001 | DEA | Schedules of Controlled Substances: Placement of Zipeprol in Schedule I DEA-2020-0015 | Schedules of Controlled Substances: Placement of Zipeprol in Schedule I | Proposed Rule | 2020-05-14T04:00:00Z | 2020 | 5 | 2020-05-14T04:00:00Z | 2020-07-14T03:59:59Z | 2020-07-14T01:01:18Z | 2020-09592 | 0 | 0 | 09000064845f501a | |
| DEA-2010-0010-0102 | DEA | Electronic Prescriptions for Controlled Substances DEA-2010-0010 | Electronic Prescriptions for Controlled Substances | Rule | 2020-04-21T04:00:00Z | 2020 | 4 | 2020-04-21T04:00:00Z | 2020-06-23T03:59:59Z | 2020-06-24T01:00:39Z | 2020-07085 | 0 | 0 | 09000064844bb877 | |
| DEA-2020-0013-0001 | DEA | Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as a Schedule II Controlled Substance DEA-2020-0013 | Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as a Schedule II Controlled Substance | Rule | 2020-04-17T04:00:00Z | 2020 | 4 | 2020-04-17T04:00:00Z | 2020-04-21T15:50:59Z | 2020-07381 | 0 | 0 | 09000064844b0e8b | ||
| DEA-2020-0012-0001 | DEA | Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals DEA-2020-0012 | Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals | Rule | 2020-04-15T04:00:00Z | 2020 | 4 | 2020-04-15T04:00:00Z | 2020-04-21T15:43:10Z | 2020-07064 | 0 | 0 | 09000064844a827d | ||
| DEA-2018-0001-0006 | DEA | Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I DEA-2018-0001 | Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I; Correction | Rule | 2020-04-10T04:00:00Z | 2020 | 4 | 2020-04-10T04:00:00Z | 2020-04-13T17:09:35Z | 2020-06984 | 0 | 0 | 090000648449963c | ||
| DEA-2019-0008-0731 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020 DEA-2019-0008 | Adjustments to Aggregate Production Quotas for Certain Schedule II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine and Pseudoephedrine for 2020, in Response to the Coronavirus Disease 2019 Public Health Emergency | Notice | 2020-04-10T04:00:00Z | 2020 | 4 | 2020-04-10T04:00:00Z | 2020-05-12T03:59:59Z | 2020-05-12T01:01:25Z | 0 | 0 | 090000648449a853 | ||
| DEA-2020-0011-0001 | DEA | Schedules of Controlled Substances: Placement of Lemborexant in Schedule IV DEA-2020-0011 | Schedules of Controlled Substances: Placement of Lemborexant in Schedule IV | Rule | 2020-04-07T04:00:00Z | 2020 | 4 | 2020-04-07T04:00:00Z | 2020-05-08T03:59:59Z | 2020-05-08T01:02:18Z | 2020-07089 | 0 | 0 | 090000648448e735 | |
| DEA-2020-0009-0001 | DEA | Schedules of Controlled Substances: Placement of 4,4'-DMAR in Schedule I DEA-2020-0009 | Schedules of Controlled Substances: Placement of 4,4′-DMAR in Schedule I | Proposed Rule | 2020-04-07T04:00:00Z | 2020 | 4 | 2020-04-07T04:00:00Z | 2020-06-09T03:59:59Z | 2020-10-19T14:31:29Z | 2020-07095 | 0 | 0 | 090000648448e827 | |
| DEA-2020-0007-0005 | DEA | Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants DEA-2020-0007 | Proposed Registration Fee Calculation Methodology | Supporting & Related Material | 2020-03-31T04:00:00Z | 2020 | 3 | 2020-03-31T20:08:40Z | 0 | 0 | 090000648447ceb7 | ||||
| DEA-2020-0010-0001 | DEA | Schedules of Controlled Substances: Placement of FUB-AMB in Schedule I DEA-2020-0010 | Schedules of Controlled Substances: Placement of FUB-AMB in Schedule I | Rule | 2020-03-30T04:00:00Z | 2020 | 3 | 2020-03-30T04:00:00Z | 2020-04-21T15:36:15Z | 2020-06176 | 0 | 0 | 09000064844770b6 | ||
| DEA-2020-0008-0001 | DEA | Controls To Enhance the Cultivation of Marihuana for Research in the United States DEA-2020-0008 | Controls To Enhance the Cultivation of Marihuana for Research in the United States | Proposed Rule | 2020-03-23T04:00:00Z | 2020 | 3 | 2020-03-23T04:00:00Z | 2020-05-23T03:59:59Z | 2020-06-05T01:02:20Z | 2020-05796 | 0 | 0 | 090000648445f2a9 | |
| DEA-2020-0007-0001 | DEA | Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants DEA-2020-0007 | Registration and Reregistration Fees: Controlled Substance and List I Chemical Registrants | Proposed Rule | 2020-03-16T04:00:00Z | 2020 | 3 | 2020-03-16T04:00:00Z | 2020-05-16T03:59:59Z | 2020-05-16T01:01:44Z | 2020-05159 | 0 | 0 | 0900006484447dc2 | |
| DEA-2020-0006-0003 | DEA | Schedules of Controlled Substances: Placement of Cenobamate in Schedule V DEA-2020-0006 | ASH Letter to Dhillon_01.15.2020 | Supporting & Related Material | 2020-03-10T04:00:00Z | 2020 | 3 | 2020-03-10T18:47:09Z | 0 | 0 | 0900006484426797 | ||||
| DEA-2020-0006-0002 | DEA | Schedules of Controlled Substances: Placement of Cenobamate in Schedule V DEA-2020-0006 | 8 Factor Cenobamate DEA March 2020 FINAL | Supporting & Related Material | 2020-03-10T04:00:00Z | 2020 | 3 | 2020-03-11T12:53:52Z | 0 | 0 | 0900006484420e81 | ||||
| DEA-2020-0006-0001 | DEA | Schedules of Controlled Substances: Placement of Cenobamate in Schedule V DEA-2020-0006 | Schedules of Controlled Substances: Placement of Cenobamate in Schedule V | Rule | 2020-03-10T04:00:00Z | 2020 | 3 | 2020-03-10T04:00:00Z | 2020-04-10T03:59:59Z | 2020-04-10T01:03:34Z | 2020-04963 | 0 | 0 | 090000648441faec | |
| DEA-2020-0006-0004 | DEA | Schedules of Controlled Substances: Placement of Cenobamate in Schedule V DEA-2020-0006 | HHS Letter to Dhillon_12.3.19 | Supporting & Related Material | 2020-03-10T04:00:00Z | 2020 | 3 | 2020-03-10T18:47:19Z | 0 | 0 | 09000064844274be | ||||
| DEA-2020-0005-0001 | DEA | Registration Requirements for Narcotic Treatment Programs with Mobile Components DEA-2020-0005 | Registration Requirements for Narcotic Treatment Programs with Mobile Components | Proposed Rule | 2020-02-26T05:00:00Z | 2020 | 2 | 2020-02-26T05:00:00Z | 2020-04-28T03:59:59Z | 2020-04-29T01:00:40Z | 2020-03627 | 0 | 0 | 09000064843b4e82 | |
| DEA-2020-0002-0005 | DEA | Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 | 8-factor 5 Fentanyl | Supporting & Related Material | 2020-02-03T05:00:00Z | 2020 | 2 | 2020-02-03T16:46:13Z | 0 | 0 | 0900006484321f48 | ||||
| DEA-2020-0003-0001 | DEA | Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V DEA-2020-0003 | Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V | Rule | 2020-01-31T05:00:00Z | 2020 | 1 | 2020-01-31T05:00:00Z | 2020-03-03T04:59:59Z | 2021-05-25T15:40:37Z | 2020-01957 | 0 | 0 | 0900006484316555 | |
| DEA-2020-0003-0009 | DEA | Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V DEA-2020-0003 | DEA 8-factor review Lasmiditan 01232020 pdf | Supporting & Related Material | 2020-01-31T05:00:00Z | 2020 | 1 | 2020-08-24T18:47:31Z | 0 | 0 | 09000064843178f0 | ||||
| DEA-2020-0002-0004 | DEA | Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 | Signed HHS Letter | Supporting & Related Material | 2020-01-31T05:00:00Z | 2020 | 1 | 2020-01-31T15:21:22Z | 0 | 0 | 090000648431707d | ||||
| DEA-2020-0002-0003 | DEA | Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 | 8-factor 5 fentanyl | Supporting & Related Material | 2020-01-31T00:00:00Z | 2020 | 1 | 2020-02-03T17:04:40Z | 0 | 1 | 090000648431718e | ||||
| DEA-2020-0002-0002 | DEA | Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 | Schedules of Controlled Substances: Extension of Temporary Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I of the Controlled Substances Act | Rule | 2020-01-30T05:00:00Z | 2020 | 1 | 2020-01-30T05:00:00Z | 2020-01-31T14:33:57Z | 2020-01683 | 0 | 0 | 090000648430a4e8 | ||
| DEA-2020-0002-0001 | DEA | Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I DEA-2020-0002 | Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl into Schedule I | Proposed Rule | 2020-01-30T05:00:00Z | 2020 | 1 | 2020-01-30T05:00:00Z | 2020-03-03T04:59:59Z | 2020-03-03T02:02:48Z | 2020-01681 | 0 | 0 | 090000648430aa75 | |
| DEA-2020-0001-0001 | DEA | Additions to Listing of Exempt Chemical Mixtures DEA-2020-0001 | Additions to Listing of Exempt Chemical Mixtures | Rule | 2020-01-27T05:00:00Z | 2020 | 1 | 2020-01-27T05:00:00Z | 2020-02-27T04:59:59Z | 2020-02-27T02:01:34Z | 2020-00667 | 0 | 0 | 09000064842f597a | |
| DEA-2016-0020-0015 | DEA | Schedules of Controlled Substances: Temporary Placement of six synthetic cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I DEA-2016-0020 | Schedules of Controlled Substances: Placement of 5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA in Schedule I | Rule | 2020-01-24T05:00:00Z | 2020 | 1 | 2020-01-24T05:00:00Z | 2020-02-03T18:59:03Z | 2020-00665 | 0 | 0 | 09000064842e7a17 | ||
| DEA-2019-0005-0007 | DEA | Schedules of Controlled Substances: Placement of Brexanolone in Schedule IV DEA-2019-0005 | Schedules of Controlled Substances: Placement of Brexanolone in Schedule IV | Rule | 2020-01-24T05:00:00Z | 2020 | 1 | 2020-01-24T05:00:00Z | 2020-02-03T17:14:07Z | 2020-00669 | 0 | 0 | 09000064842e7d87 | ||
| DEA-2020-0004-0001 | DEA | Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control DEA-2020-0004 | Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control | Rule | 2020-01-24T05:00:00Z | 2020 | 1 | 2020-01-24T05:00:00Z | 2020-02-03T18:20:33Z | 2020-00664 | 0 | 0 | 09000064842e7d17 | ||
| DEA-2019-0006-0005 | DEA | Schedules of Controlled Substances: Placement of Solriamfetol in Schedule IV DEA-2019-0006 | Schedules of Controlled Substances: Placement of Solriamfetol in Schedule IV | Rule | 2020-01-07T05:00:00Z | 2020 | 1 | 2020-01-07T05:00:00Z | 2020-01-22T15:01:40Z | 2019-27955 | 0 | 0 | 0900006484275aec |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;